Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30.In trading on Tuesday, shares of CommerceHub Inc ( CHUBA) entered into oversold territory, hitting an RSI reading of 27.8, after changing hands as low as $21.54 per share. By comparison, the current RSI reading of the S&P 500 ETF (SPY) is 73.6. A bullish investor could look at CHUBA's 27.8 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. The chart below shows the one year performance of CHUBA shares: Looking at the chart above, CHUBA's low point in its 52 week range is $13.24 per share, with $24.53 as the 52 week high point — that compares with a last trade of $21.59. According to the ETF Finder at ETF Channel, CHUBA makes up 1.76% of the PowerShares Dynamic Software Portfolio ETF ( PSJ) which is trading relatively unchanged on the day Tuesday.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
2 Enigmatic Indices, Intriguing Oil, and Planet Fitness Slouches: Market Recon
Plus, a look at Ulta Beauty and a possible options play in the retailer.
Take-Two Interactive Looks Better on the Charts Than Activision Blizzard
Let's check out the charts of TTWO this morning.
Dow Futures Flat, Dollar Sips as Trade Concerns Trim Risk Appetite Ahead of G20
U.S. equity futures drifted lower Tuesday, setting up the S&P 500 for its first three-day decline since early May, as investors peel back from recent record highs and take a defensive stance on risk ahead of this weekend's G20 Summit in Japan.
Allergan Agrees to $63 Billion Takeover From AbbVie in Blockbuster Pharma Deal
Allergan shares surge in premarket trading Tuesday after it agreed to a $63 billion takeover from biopharmaceutical group AbbVie.